Alternative splicing isoforms in health and disease

HK Kim, MHC Pham, KS Ko, BD Rhee… - Pflügers Archiv-European …, 2018 - Springer
Alternative splicing (AS) of protein-coding messenger RNAs is an essential regulatory
mechanism in eukaryotic gene expression that controls the proper function of proteins. It is …

Cardiomyopathies due to left ventricular noncompaction, mitochondrial and storage diseases, and inborn errors of metabolism

JA Towbin, JL Jefferies - Circulation research, 2017 - Am Heart Assoc
The normal function of the human myocardium requires the proper generation and utilization
of energy and relies on a series of complex metabolic processes to achieve this normal …

RBM20, a gene for hereditary cardiomyopathy, regulates titin splicing

W Guo, S Schafer, ML Greaser, MH Radke, M Liss… - Nature medicine, 2012 - nature.com
Alternative splicing has a major role in cardiac adaptive responses, as exemplified by the
isoform switch of the sarcomeric protein titin, which adjusts ventricular filling. By positional …

Multiple phenotypes in phosphoglucomutase 1 deficiency

LC Tegtmeyer, S Rust… - … England Journal of …, 2014 - Mass Medical Soc
Background Congenital disorders of glycosylation are genetic syndromes that result in
impaired glycoprotein production. We evaluated patients who had a novel recessive …

Nanodomain cAMP signalling in cardiac pathophysiology: potential for developing targeted therapeutic interventions.

M Zaccolo, D Kovanich - Physiological reviews, 2024 - journals.physiology.org
3', 5'-cyclic adenosine monophosphate (cAMP) mediates the effects of sympathetic
stimulation on the rate and strength of cardiac contraction. Beyond this pivotal role, in …

The role of Z-disc proteins in myopathy and cardiomyopathy

K Wadmore, AJ Azad, K Gehmlich - International Journal of Molecular …, 2021 - mdpi.com
The Z-disc acts as a protein-rich structure to tether thin filament in the contractile units, the
sarcomeres, of striated muscle cells. Proteins found in the Z-disc are integral for maintaining …

CDG therapies: from bench to bedside

S Brasil, C Pascoal, R Francisco… - International journal of …, 2018 - mdpi.com
Congenital disorders of glycosylation (CDG) are a group of genetic disorders that affect
protein and lipid glycosylation and glycosylphosphatidylinositol synthesis. More than 100 …

Molecular genetics and pathogenesis of cardiomyopathy

A Kimura - Journal of human genetics, 2016 - nature.com
Cardiomyopathy is defined as a disease of functional impairment in the cardiac muscle and
its etiology includes both extrinsic and intrinsic factors. Cardiomyopathy caused by the …

Modeling structural and functional deficiencies of RBM20 familial dilated cardiomyopathy using human induced pluripotent stem cells

SP Wyles, X Li, SC Hrstka, S Reyes… - Human molecular …, 2016 - academic.oup.com
Dilated cardiomyopathy (DCM) is a leading cause of heart failure. In families with autosomal-
dominant DCM, heterozygous missense mutations were identified in RNA-binding motif …

AAV-based gene therapy prevents and halts the progression of dilated cardiomyopathy in a mouse model of phosphoglucomutase 1 deficiency (PGM1-CDG)

B Balakrishnan, R Altassan, R Budhraja, W Liou… - Translational …, 2023 - Elsevier
Abstract Phosphoglucomutase 1 (PGM1) deficiency is recognized as the third most common
N-linked congenital disorders of glycosylation (CDG) in humans. Affected individuals …